These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11228175

  • 21. Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant.
    Mourad G, Karras A, Kamar N, Garrigue V, Legendre C, Lefrançois N, Charpentier B, Bourbigot B, Pouteil-Noble C, Bayle F, Lebranchu Y, Mariat C, Le Meur Y, Kessler M, Moulin B, Ducloux D, Delahousse M, Lang P, Merville P, Chaouche-Teyara K, Rostaing L, French Myriade FR01 Study Group.
    Clin Transplant; 2007; 21(3):295-300. PubMed ID: 17488375
    [Abstract] [Full Text] [Related]

  • 22. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 23. Co-administration of cyclosporine and ketoconazole in children with minimal change nephrotic syndrome.
    El-Husseini A, El-Basuony F, Donia A, Mahmoud I, Hassan N, Sayed-Ahmad N, Sheashaa H, Sabry A, Sobh M.
    Nephron Clin Pract; 2005 Nov; 100(2):c27-32. PubMed ID: 15775719
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y, Zhang XD, Wang Y.
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [Abstract] [Full Text] [Related]

  • 25. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 26. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM.
    Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345
    [Abstract] [Full Text] [Related]

  • 27. Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.
    Videla C, Vega J, Borja H.
    Transplant Proc; 2005 Apr 27; 37(3):1574-6. PubMed ID: 15866677
    [Abstract] [Full Text] [Related]

  • 28. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
    Schweiger M, Wasler A, Prenner G, Stiegler P, Stadlbauer V, Schwarz M, Tscheliessnigg K.
    Transpl Immunol; 2006 Jun 27; 16(1):46-51. PubMed ID: 16701176
    [Abstract] [Full Text] [Related]

  • 29. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 27; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 30. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
    Romagnoli J, Citterio F, Nanni G, Favi E, Tondolo V, Spagnoletti G, Salerno MP, Castagneto M.
    Transplant Proc; 2006 May 27; 38(4):1034-6. PubMed ID: 16757255
    [Abstract] [Full Text] [Related]

  • 31. Single daily dose administration of cyclosporine in renal transplant recipients.
    Halim MA, Said T, Al-Otaibi T, Eleawa S, Al-Maged H, Gawish AE, Nair P, Al-Muzairai I, Nampoory MR, Al-Mousawi M.
    Transplant Proc; 2007 May 27; 39(4):1225-7. PubMed ID: 17524939
    [Abstract] [Full Text] [Related]

  • 32. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation.
    Valantine H, Keogh A, McIntosh N, Hunt S, Oyer P, Schroeder J.
    J Heart Lung Transplant; 1992 May 27; 11(1 Pt 1):1-7; discussion 7-8. PubMed ID: 1540597
    [Abstract] [Full Text] [Related]

  • 33. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
    Sommerer C, Giese T, Schmidt J, Meuer S, Zeier M.
    Transplantation; 2008 Jan 15; 85(1):15-21. PubMed ID: 18192906
    [Abstract] [Full Text] [Related]

  • 34. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 15; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 35. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 15; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 36. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan 15; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 37. Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study.
    Sobh M, el-Agroudy A, Moustafa F, Harras F, el-Bedewy M, Ghoneim M.
    Am J Nephrol; 1995 Jan 15; 15(6):493-9. PubMed ID: 8546171
    [Abstract] [Full Text] [Related]

  • 38. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome.
    Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL.
    Transplantation; 1994 Mar 27; 57(6):889-92. PubMed ID: 8154037
    [Abstract] [Full Text] [Related]

  • 39. Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis.
    El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmed N, Sobh M.
    Am J Nephrol; 2004 Mar 27; 24(3):301-6. PubMed ID: 15133323
    [Abstract] [Full Text] [Related]

  • 40. Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis.
    el-Husseini A, el-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmad N, Sobh M.
    Pediatr Nephrol; 2004 Sep 27; 19(9):976-81. PubMed ID: 15241676
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.